More and more people are talking about Bath & Body Works over the last few weeks. Is it worth buying the Specialty Retail stock at a price of $43.23? Only time will tell. The information below will give you a basic idea of what this investment may entail:
-
Bath & Body Works has moved -7.6% over the last year, and the S&P 500 logged a change of 19.5%
-
BBWI has an average analyst rating of buy and is 1.46% away from its mean target price of $42.61 per share
-
Its trailing earnings per share (EPS) is $3.14
-
Bath & Body Works has a trailing 12 month Price to Earnings (P/E) ratio of 13.8 while the S&P 500 average is 15.97
-
Its forward earnings per share (EPS) is $3.32 and its forward P/E ratio is 13.0
-
Bath & Body Works is part of the Consumer Cyclical sector, which has an average P/E ratio of 22.96 and an average P/B of 4.24
-
BBWI has reported YOY quarterly earnings growth of 30.3% and gross profit margins of 0.4%
-
The company has a free cash flow of $575.25 Million, which refers to the total sum of all its inflows and outflows of cash over the last quarter
-
Bath & Body Works, Inc. operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements. The company was formerly known as L Brands, Inc. and changed its name to Bath & Body Works, Inc. in August 2021. Bath & Body Works, Inc. was founded in 1963 and is headquartered in Columbus, Ohio.
